Retatrutide (Reta)
Retatrutide is a triple agonist peptide that simultaneously activates GLP-1 (glucagon-like peptide-1), GIP(glucose-dependent insulinotropic polypeptide), and glucagon receptors. It is one of the most potent weight-loss agents currently in late-stage clinical development.
Choose your dosage
Purity: 99%
Form: Lyophilized Powder
Description
DEFINITION
Retatrutide is a triple agonist peptide that simultaneously activates GLP-1 (glucagon-like peptide-1), GIP
(glucose-dependent insulinotropic polypeptide), and glucagon receptors. It is one of the most potent weight-loss
agents currently in late-stage clinical development.
KEY BENEFITS
■Significant weight reduction — clinical trials show up to 24% body weight loss
â– Improved glycemic control and insulin sensitivity
â– Reduction in appetite and caloric intake via multiple receptor pathways
â– Favorable effects on lipid profiles and cardiovascular risk markers
â– Potential benefits for non-alcoholic fatty liver disease (NAFLD)
Available Quantities
20mg
30mg
All products are sold for research and laboratory use only.
